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Endogenous tryptophan (Trp) metabolites have an
important role in mammalian gut immune homeosta-
sis, yet the potential contribution of Trp metabolites
from resident microbiota has never been addressed
experimentally. Here, we describe a metabolic
pathway whereby Trp metabolites from the micro-
biota balance mucosal reactivity in mice. Switching
from sugar to Trp as an energy source (e.g., under
conditions of unrestricted Trp availability), highly
adaptive lactobacilli are expanded and produce
an aryl hydrocarbon receptor (AhR) ligand—indole-
3-aldehyde—that contributes to AhR-dependent
Il22 transcription. The resulting IL-22-dependent
balanced mucosal response allows for survival of
mixed microbial communities yet provides coloni-
zation resistance to the fungus Candida albicans
and mucosal protection from inflammation. Thus,
the microbiota-AhR axis might represent an impor-
tant strategy pursued by coevolutive commensalism
for fine tuning host mucosal reactivity contingent on
Trp catabolism.
INTRODUCTION
Indoleamine 2,3-dioxygenase 1 (IDO1), a ‘‘metabolic’’ enzyme
conserved through the past 600 million years of evolution,
degrades tryptophan (Trp), suppresses inflammation, and is
involved in mammals in the peripheral generation of regulatory
T (Treg) cells, an event requiring the combined effects of Trp
starvation and a series of endogenous Trp catabolites collec-
tively known as ‘‘kynurenines’’ (Puccetti and Grohmann, 2007).
In particular, L-kynurenine, the first breakdown product in the
IDO1-dependent Trp degradation pathway, activates the aryl
hydrocarbon receptor (AhR) in lymphoid tissues (Opitz et al.,
2011) and promotes Treg cell development (Fallarino et al.,
2006; Mezrich et al., 2010). In the gastrointestinal tract, diet-
derived AhR ligands promote local IL-22 production (Lee et al.,
2012) by innate lymphoid cells (ILCs) (Qiu et al., 2012), now372 Immunity 39, 372–385, August 22, 2013 ª2013 Elsevier Inc.referred to as group 3 ILCs (ILC3s) (Spits et al., 2013). Metabolo-
mic analysis has revealed that gut bacteria impact host meta-
bolism and immunity through a variety of chemically different
metabolites, including amino acid metabolites (Wikoff et al.,
2009). In particular, dietary lack of Trp impairs intestinal immunity
in mice and alters the gut microbial community (Hashimoto et al.,
2012), suggesting that mucosal homeostasis is a multifactorial
phenomenon of which Trpmetabolism is an important regulatory
component. However, the source and nature of any such AhR
ligands, any impact of microbial dysbiosis on AhR- and IL-22-
driven mucosal reactivity, and whether AhR activation by micro-
biota-derived metabolites also occurs have all been unclear.
Candida albicans is a commensal of the orogastrointestinal
tract, vagina, and skin (Romani, 2011). Owing to microbial dys-
biosis or defects in the innate and adaptive immune systems,
the fungus shifts from commensalism to parasitism, and it might
cause severe infections, such as the oropharyngeal, vulvovagi-
nal, and chronic mucocutaneous forms of human candidiasis.
In combination with IL-17A, IL-22 mediates a pivotal innate anti-
fungal resistance in mice (De Luca et al., 2010) and humans (Puel
et al., 2010). These cytokines are regulated by the intestinal
microbiota (Ivanov et al., 2009; Satoh-Takayama et al., 2008).
This could not only explain the high risk of mucosal candidiasis
after antibiotic therapy in humans (Sobel, 2007) and gnotobiotic
mice (Balish et al., 1993) but also suggest an interplay between
Trp catabolism bymicrobiota, the host’s own pathway of metab-
olite production, and AhR-orchestrated mucosal function.
Here, we used Ido1/mice and dietary Trp feeding to investi-
gate any links among Trp catabolism in the host, activation of
theAhR-IL-22 axis, and the role ofmicrobiota inmucosal immune
homeostasis in the gut. By correlating changes inmetabolite pro-
fileswithmicrobiotametagenomic composition, we have defined
a functional node by which lactobacilli contribute to host-micro-
bial symbiosis and homeostasis at mucosal surfaces.RESULTS
The AhR-IL-22 Axis Provides Resistance to Mucosal
Candidiasis in Ido1–/– Mice
To examine any effects of host-extrinsic Trp catabolism on
AhR-dependent IL-22 production and colonization resistance
to Candida, we analyzed Ido1/ or Ahr/ mice with or without
Figure 1. The AhR-IL-22 Axis Provides Antifungal Resistance in Ido1–/– Mice
(A and B) IL-22 production (ELISA) by PPs (A) and purified PP-NKp46+ cells (B) stimulated with IL-2 and IL-23 in vitro.
(C) IL-22 production (ELISA) in vivo in the stomach of mice naive infected with Candida albicans intragastrically.
(D and E) Number of NKp46+ IL-22+ cells (D) and immunostaining with anti-NKp46-FITC and anti-iL-22-PE antibody (E) in the stomach at different days post-
infection. Cell nuclei were stained with DAPI (in blue). Scale bars represent 20 mm (dpi 0, naive mice).
(F and G) Colony-forming units (cfu) in the stomach (F) and stomach histology (3 dpi) (G). Red arrows indicate fungi, black arrows indicate inflammatory cells, and
arrowheads indicate epithelial ulceration in sections stained with periodic acid Schiff. Images were acquired with a 403 objective. Scale bars represent 100 mm.
(H and I) Fungal growth (H) and stomach histology (I) (3 dpi) of infected mice treated with IL-22 mAb neutralizing antibody. Red arrows indicate fungi, and black
arrows indicate inflammatory cells. Scale bars represent 100 mm. ‘‘None’’ refers to isotype control antibody.
Results shown are compiled data from four independent experiments (means ± SD) or a representative image. All error bars represent the SD of samples within a
group. *p < 0.05, **p < 0.01. ‘‘NS’’ stands for not significant. Control littermates of the genetically deficient mice—occasionally tested in parallel with wild-type
(WT) hosts in these and subsequent experiments—showed a pattern of reactivity indistinguishable from the latter. See also Figure S1.
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Lactobacilli Regulate Mucosal IL-22 via AhRinfection. Higher amounts of IL-22 were found in Peyer’s patches
(PPs) (Figure 1A), in NKp46+ cells fromPPs (Figure 1B), and in the
stomachs of naive (0 days postinfection [dpi]) Ido1/ mice thanin their wild-type (WT) counterparts (Figure 1C). After oral infec-
tion with C. albicans, the amounts of IL-22 were still higher in
the stomach, a target organ in candidiasis, of Ido1/ miceImmunity 39, 372–385, August 22, 2013 ª2013 Elsevier Inc. 373
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Lactobacilli Regulate Mucosal IL-22 via AhR(Figure 1C) and correlated with the expansion of NKp46+ cells
producing IL-22, as revealed by cell number (Figure 1D) and
immunofluorescence staining (Figure 1E, 3 dpi). IL-22-producing
NKp46+NK1.1lo cells, expressing lineage-specific transcripts
(Figure S1A, available online), also expanded in the PPs (Fig-
ure S1B). IL-17F and IL-10, but not IL-17A (Figure S1C), were
also higher in the stomach (Figure S1C), esophagus (Figure S1D),
and ileum (Figure S1E) of Ido1/ mice. Fewer signs pathogno-
monic for infection were observed in those mice, as revealed
by restricted fungal growth (Figure 1F) and low-grade histopa-
thology in the stomach (Figure 1G).
In this setting, dependency of the anticandidal resistance on
functional AhR and IL-22 production was demonstrated by the
detrimental effects of genetic AhR deficiency (Figures 1F and
1G), which would per se negate IL-22 production (Figure 1C)
and ILC3 expansion (Figures 1D and 1E), and by IL-22 neutraliza-
tion experiments in infected Ido1/mice (Figures 1H and 1I and
Figure S1F). Overall, these data suggest that sources of AhR
ligands—other than host kynurenines—can influence or even
enhance mucosal reactivity to Candida.
Lactobacilli Expand in the Stomachs
of IDO1-Deficient Mice
Of the dietary Trp that is not used in protein synthesis, 99% is
metabolized in mammals by IDO1 (Puccetti and Grohmann,
2007).Thus, increased Trp availability in the gut of Ido1/
mice could alter both the qualitative composition and the meta-
bolic pathways in the local mixed microbial community. We
searched for qualitative and/or quantitative changes in microbial
communities from fecal samples and the stomach—whose
metagenomic profile is far less characterized than that of
feces—by barcoded pyrosequencing of 16S rRNA. Upon
analyzing a total of 620,369 reads with a median length of
365.4 bp, we found that WT and Ido1/ mice, either uninfected
or infected with Candida, displayed similar relative abundances
of major bacterial phyla in the stomach (Firmicutes predomi-
nated, and Bacteroidetes and Proteobacteria were the next
most abundant) (Figure 2A). Both types of mice shared most
taxa at the family levels within Firmicutes (e.g., Lactobacillaceae,
Clostridiaceae, Ruminococcaceae, Lachnospiracae, and Erysi-
pelotrichaceae) (Figure 2B), Bacteroidetes (e.g., uncultured
Bacteroidetes, Prevotellaceae, Rikenellaceae, Bacteroidaceae,
Porphyromonaceae, and others) (Figure 2C), and Proteobacteria
(e.g., Enterobacteriaceae, Suterellaceae, Desulfovibrionaceae,Figure 2. Bacterial 16S-rRNA-Based Analysis of the Stomach Microbio
(A–D) Relative abundance of major bacterial phyla (A) and bacterial taxa (B–D) in th
or at 3 dpi.
(E) Counts of bacteria in the stomach of naive or infected (3 dpi) mice. **p < 0.01,
from four independent experiments (means ± SD).
(F) Stomach SEM of infected mice. Arrows indicate the presence of bacilli of L. re
represent 10 mm.
(G) Identification of lactobacilli and L. reuteri (red) in the gastric fluids of mice by F
stands for pure cultures of bacteria. Bacteria counterstained with DAPI are in blu
(H) The taxonomic distribution of themost abundant Lactobacillus species is show
the use of the k-nearest-neighbor classifier SeqMatch from the Ribosomal Datab
(I) L. reuteri in the stomach by quantitative PCR analysis of 16S rRNA. Data are r
(J) Lactobacilli communities in the stomach from individualmice (each point) are cl
UniFrac distances. Percentages of variation explained by plotted principal coord
Related data are in Figures S2 and S3.Rhodocyclaceae, Alcaligenaceae, and uncultured Proteobac-
teriae) (Figure 2D) (Tables S1–S4). However, closer examination
of the relative abundance of taxa in Firmicutes revealed notice-
able differences between Ido1/ and WT mice. Lactobacilli
predominated over Clostridia in Ido1/ mice, whether naive or
after infection (Figures 2B and 2E). Scanning electron micro-
scopy (Figure 2F) and fluorescence in situ hybridization (FISH)
(Figure 2G) confirmed that Lactobacillus morphotypes were
abundant in the stomach, and lactobacilli could be identified
in gastric fluids from Ido1/ mice. Lactobacilli were also
expanded by infection in the esophagus (104/g versus 102/g;
Figure S2A) and ileum (106/g versus 105/g; Figure S2B) of
Ido1/ mice.
Distinct species of the Lactobacillus genus are present in the
murine intestinal tract and are grouped in several taxa on the
basis of, among other parameters, resistance or susceptibility
to vancomycin (Pen˜a et al., 2004). We found striking differences
at the level of lactobacilli species between Ido1/ andWTmice,
either naive or carrying infection. L. johnsonii, a member of the
vancomycin-sensitive acidophilus group, found as a commensal
in humans (Pridmore et al., 2004) and abundantly present in
rodents (Jenq et al., 2012), was most abundant in both types
of mice, either naive or infected (Figure 2H and Figure S2C). In
contrast, vancomycin-resistant L. reuteri—amodel gut symbiont
in vertebrates as a result of host-driven evolution (Walter et al.,
2011)—was poorly represented in naive WT mice but expanded
upon infection to a degree comparable to that seen in naive
Ido1/ mice, in which a further striking increase was observed
after infection (Figure 2H and Figure S2C). FISH analysis with a
L. reuteri-specific fluorescent probe (Figure 2G), unreactive to
other Lactobacillus species in gastric fluids (Figure S2D), and
quantitative PCR on amplifying 16S rRNA genes (Figure 2I)
confirmed the expansion of L. reuteri in the stomachs of Ido1/
mice. In addition, FISH analysis showed copresence of
L. johnsonii, but not L. acidophilus (Figure S2E). Microbial
profiling of fecal samples showed that L. reuteri was also highly
represented in those mice (Figure S2F).
Differences within lactobacilli in the stomach (Figure 2J) and
feces (Figure S2G) of Ido1/ and WT mice were confirmed
by unweighted and weighted UniFrac distance analysis, which
takes into account the presence or absence and evolutionary
relatedness of operational taxonomical units (OTUs), and by
subsequent principal-coordinate analysis, the first principal co-
ordinate (P1) of which explained most of the variance in eachta of WT and Ido1–/– Mice
e stomachmicrobiota from C57BL/6 and Ido1/ littermates, either uninfected
***p < 0.005. ‘‘NS’’ stands for not significant. Results shown are compiled data
uteri-like morphologies (short, pleomorphic cells with round edges). Scale bars
ISH analysis using bacterial-specific probes. Scale bars represent 10 mm. ‘‘Ct’’
e. Images are representative of two experiments.
n. Species nameswere assigned to organizational taxonomic units (OTUs) with
ase Project.
epresented as means ± SD. *p < 0.05.
ustered according to principal-coordinate analysis of unweighted andweighted
inates P1 and P2 are indicated on the x and y axes, respectively.
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Lactobacilli Regulate Mucosal IL-22 via AhRsample between WT and Ido1/mice and the second principal
coordinate (P2) of which showed a high degree of similarity
among all samples. In accordance with the ability of lactobacilli
to inhibit autochthonous uncultivable segmented filamentous
bacteria (SFB) (Fuentes et al., 2008), SFB, abundantly present
in the distal ilea of naive Ido1/mice, were markedly decreased
in these mice by Candida infection (Figures S3A and S3B). The
microbial composition and lactobacilli species in the stomachs
of C57BL/6 mice bred at Charles River Laboratories (Calco)
was similar to that of C57BL/6 mice bred at The Jackson Labo-
ratory (Bar Harbor) (Figure S3C), thus ruling out the existence of
variation from colony to colony. Therefore, lactobacilli are the
dominant microbiota in the mouse stomach (Tannock et al.,
1982), and IDO1 deficiency is permissive for L. reuteri to estab-
lish a niche there.
L. reuteri Is Selectively Expanded as a Result
of Unrestricted Availability of Trp
Lactobacilli are nutritionally fastidious anaerobes and rely on the
availability of easy fermentable sugars, amino acids, vitamins,
and nucleotides. In vivo expression technology has shown that
lactobacilli might undergo gut-specific gene expression in order
to adapt (Frese et al., 2011). Both L. johnsonii (Denou et al., 2007)
and L. reuteri (Frese et al., 2011; Walter et al., 2011) are very
active transcriptionally in the stomach, where distinct nutritional
adaptations provide niche differentiation that allows cohabita-
tion by the two strains in the mouse forestomach (Tannock
et al., 2012). Because lactobacilli are typically auxotrophic for
several amino acids and are capable, under carbohydrate-
starvation conditions, of catabolizing L-Trp to bioactive indole
derivatives (Gummallaa and Broadbent, 1999), we reasoned
that under conditions of high levels of Trp, lactobacilli might
switch from sugar to Trp as an energy source. We measured
Trp levels in Ido1/ and WT mice and assessed the conse-
quences of exposure to Trp, over that range, on the growth
and metabolic activity of L. reuteri and L. johnsonii. We found
that Trp levels were much higher in Ido1/ mice than in WT
mice and that levels of L-kynurenines were considerably lower
(Figure S4A). Exposure to concentrations of Trp in the range
of Ido1/ mice (0.4–0.6 mM) greatly promoted growth of
L. reuteri, but not of L. johnsonii, whose growth was, in fact,
inhibited (Figure S4B). Growth of L. reuteri was also promoted
in the presence of epithelial cells in which Ido1 expression had
been inhibited by siRNA technology (Figure S4C), suggesting
that an increased Trp availability in Ido1/ mice would selec-
tively expand L. reuteri while promoting alternate pathways of
Trp degradation in the population being expanded.Figure 3. Lactobacilli Induce IL-22 via IAld, a Trp-Indole Derivative
(A) The Trp metabolic pathways, enzymes, and molecular structures of Trp-indo
(B–D) Peak levels of IAld in broth cultures (peptone-tryptone water [PT-CM] v
lactobacilli (C), and gastric fluids and urine (D) from naive or infected (3 dpi) mice
follows: IAM, indole-3-acetamide; IAA, indole-3-acetic acid; and ILA, indole-3-la
(E and F) IL-22 levels (ELISA) in ex vivo stomach cultured with MALP-2, IAld, U
MRS-CM for 24 hr (E) and supernatants of purified PP-NKp46+ cells stimulated i
(G) Peak levels of IAld in PT-CM and MRS-CM of L. reuteri 100-23 (WT) and its D
(H) IL-22 levels in ex vivo stomach exposed to the two Lactobacillus strains. D
experiments and represent the mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001.
Related data are in Figures S4 and S5.Lactobacilli Produce Indole-3-Aldehyde, a Trp-Indole
Derivative
A variety of indole derivatives act as AhR ligands (Chung and
Gadupudi, 2011), which are generated through catabolism of
dietary Trp along the ‘‘indole pathway’’ (Figure 3A) by mostly
anaerobic intestinal bacteria with tryptophanase activity (Wikoff
et al., 2009). We employed targeted metabolomics to detect
indole derivatives both in vivo during infection and in vitro in
conditioned media (CM) from L. reuteri and L. johnsonii, which,
recovered from the stomach of Ido1/ mice, were grown in the
presence of 0.4–0.6 mM Trp with (MRS broth) or without
(peptone-tryptone water) carbohydrates. Metabolic profiling
revealed that, of the different putative metabolites, indole-3-
aldehyde (IAld), a molecule with AhR ligand activity (Figure S4D),
was abundantly produced by L. reuteri and only poorly by
L. johnsonii in the presence of Trp under carbohydrate-starva-
tion conditions (Figure 3B). IAld was also detected in ex vivo
cultures of the stomachs exposed to L. reuteri, but not
L. johnsonii (Figure 3C). In infection, IAld was detected in
the gastric fluids and urine, where excretion of specific
metabolites reflects pathways in Trp metabolism (Figure 3D),
and it was maximally produced in Ido1/ mice (Figure 3D
insets). IAld was not produced by Clostridia or indole-positive
bacteria with tryptophanase activity (Figure S4E), nor were
indole levels higher in Ido1/ mice than in WT mice (Fig-
ure S4F). Overall, the bulk of these data demonstrate that
IAld-producing lactobacilli (rather than tryptophanase-compe-
tent organisms or Clostridia) are mostly expanded and utilize
Trp in Ido1/ mice.
IAld is a metabolite derived from Trp via several pathways
(Figure 3A). The indole pyruvate (IPyA) route is one of the main
pathways for IAld synthesis from Trp (Trp/IPyA/ IAld) and is
catalyzed by the aromatic amino acid aminotransferase (ArAT),
a key enzyme phylogenetically conserved in many bacterial spe-
cies, including lactobacilli, but not Clostridia spp., belonging in
the clusters IV and XIVa, which are dominant in the murine gut
(Atarashi et al., 2011) (Figure S4G). Although transamination of
Trp belongs in minor pathways of amino acid metabolism,
ArAT plays a major role in the conversion of aromatic amino
acids to aroma compounds by lactobacilli (Rijnen et al., 1999).
We assessed whether any enzyme with ArAT-type activity
is involved in IAld production by L. reuteri. We found that
Lreu23DRAFT_4905, encoding an ArAT-related aminotrans-
ferase (Figure S5A) (http://jgi.doe.gov/), was maximally ex-
pressed in L. reuteri under conditions of high Trp levels and
low carbohydrate levels (Figure S5B). We were also able to
confirm the crucial role of this aminotransferase in Trp utilizationle derivatives. Asterisks indicate metabolites with AhR agonistic activity.
ersus MRS [MRS-CM]) (B), supernatants from ex vivo stomach exposed to
(insets show quantification; data represent means ± SD). Abbreviations are as
ctic acid.
V-inactivated lactobacilli, and supernatants of lactobacilli grown in PT-CM or
n vitro with IAld (F).
Lreu4905 mutant.
ata are representative (metabolomics) of or compiled (IL-22 assay) from five
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DLreu4905) of L. reuteri 100-23, a highly adaptive strain from
the murine gut (Walter et al., 2011). The mutant was still capable
of growing in the presence of externally added Trp (Figure S5C)
yet was unable to produce IAld (Figure 3G). Importantly, at vari-
ance with L. reuteri, araT in L. johnsonii FI9785 (National Center
for Biotechnology Information [NCBI] GI 268319536) (53% iden-
tity, p = 1 3 10137, by a translated nucleotide query in BLASTx
[http://www.blast.ncbi.nlm.nih.gov/]) was not upregulated in
high-Trp growing conditions (Figure S5B). In line with the defec-
tive growth of L. johnsonii under high Trp levels (Figure S4B),
the lack of the pyruvate dehydrogenase complex and other
enzymes required for conversion of pyruvate to acetaldehyde
in this strain (Boekhorst et al., 2004), and the role of sugar,
more than amino acid, digestion in affecting its gut persistence
(Denou et al., 2008), this finding suggests that L. reuteri, more
than L. johnsonii, is equipped with the appropriate metabolic
machinery for Trp utilization in the stomach.
Lactobacilli Induce IL-22 via IAld
To investigate the role of IAld in AhR-dependent IL-22 produc-
tion in infection, we measured IL-22 production in ex vivo
cultures of gastric specimens exposed to a physiologically rele-
vant concentration of IAld or to supernatants of L. reuteri or
L. johnsonii grown in the presence of Trp. Owing to the ability
of Toll-like receptor 2 (TLR2) to regulate IL-22 production (Crellin
et al., 2010), we also used inactivated lactobacilli and MALP-2, a
TLR2 agonist, as stimuli. The results indicated a dual mechanism
of IL-22 production, i.e., through direct microbial recognition via
TLR2 and MyD88 (mostly exploited by L. johnsonii in WT mice)
and via IAld (mostly exploited by L. reuteri in Ido1/ mice) (Fig-
ure 3E). Importantly, IAld also induced IL-22 by purified NKp46+
cells (Figure 3F). Lactobacilli-induced IL-22 occurred in severe
combined immunodeficient (SCID) mice and in IL-17A-deficient
mice (Figure S5D), i.e., through innate immune mechanisms
and independently of IL-17A. Cytokines other than IL-22 were
induced by other intestinal bacteria (Figure S5E). Not only was
the araTmutant (DLreu4905) described above unable to produce
IAld (Figure 2G), but it was also incapable of producing IL-22
(Figure 2H). Thus, lactobacilli, but not other intestinal bacteria,
induce IL-22 via IAld in Ido1/ mice.
Dietary Trp Affects Amounts of IAld and IL-22
in the Stomach
To investigate whether lactobacilli expand and produce IAld un-
der physiologically relevant conditions, we evaluated resistance
to candidiasis in conventional mice fed a Trp-enriched (Trp+) or
Trp-low (Trp) diet for 4 weeks and treated with ampicillin that
promotes a long-lasting depletion of lactobacilli, among others,
in the ileum and cecum (Jenq et al., 2012; Ubeda et al., 2010)
(minimum inhibitory concentration [MIC] ranges of L. reuteri
and L. johnsonii isolated from the murine stomach were
0.15–2.50 and 0.25–1.00 mg/ml, respectively, on susceptibility
testing). We found that ampicillin and chronic restriction of
Trp both decreased antifungal resistance in WT and Ido1/
mice, whereas in WT mice, Trp feeding increased antifungal
resistance, which was negated by ampicillin (Figure 4A) (inci-
dentally, psoriatic-like lesions were observed in Trp-fed Ido1/
mice; Figure S6A). The degree of resistance correlated with the378 Immunity 39, 372–385, August 22, 2013 ª2013 Elsevier Inc.local expression of Lreu23DRAFT_4905 (Figure 4B), IAld (Fig-
ure 4C), IL-22 (Figure 4D), and IL-22-producing ILC3s (Fig-
ure 4E) in the stomach; all were higher in Trp-fed WT mice
and lower in mice treated with ampicillin or on a low-Trp diet.
Scanning electron microscopy (Figure 4F) and FISH (Figure 4G)
analyses confirmed a decreased lactobacilli content in the
stomach after ampicillin treatment and chronic restriction of
Trp and the selective expansion of L. reuteri upon Trp feeding.
Ampicillin did not expand other commensals, such as Clos-
tridia, in the stomach (Figure S6B), nor did it eliminate SFB
from the ileum (Figure S6C). Accordingly, treatment with vanco-
mycin, which inhibits Th17-inducing SFB in the ileum (Ivanov
et al., 2009), as well as Bacteroidetes from the cecum (Ubeda
et al., 2010), slightly decreased antifungal resistance in WT,
but not in Ido1/, mice (Figure S6D), a finding pointing to a
minor role for SFB and Bacteroidetes in providing antifungal
resistance under conditions of high amounts of Trp. We could
confirm that, within the species-dependent susceptibility of lac-
tobacilli to vancomycin (Pen˜a et al., 2004), L. johnsonii from
the mouse stomach was susceptible (MIC range of 1.50–
3.00 mg/ml) and L. reuteri was resistant (MIC > 256 mg/ml).
Thus, these data support the observation that gut amounts
of Trp impact gut ecology (Hashimoto et al., 2012) and, spe-
cifically, that vancomycin-resistant but ampicillin-sensitive
L. reuteri expand in the stomach upon Trp feeding and affect
local immune homeostasis.
Lactobacilli Exert Species-Specific Probiotic Effects
in Candidiasis
We next assessed the species-specific probiotic effects of lac-
tobacilli in vivo by employing several experimental approaches
that did not intentionally include lactobacilli-free mice, because
these animals also lack SFB (Tannock and Archibald, 1984). We
assessed antifungal resistance in germ-free (GF) mice, whose
stomach is a target organ in candidiasis (Balish et al., 1993),
and conventional mice after gut decontamination by prolonged
antibiotic treatment. We reconstituted mice with L. reuteri
100-23, its DLreu4905 mutant, and murine L. johnsonii.
Although equally capable of colonizing mice (Figure S7A),
L. reuteri 100-23 fully restored antifungal resistance in GF
mice, an effect only minimally afforded by the L. reuteri mutant
or L. johnsonii, as indicated by the restrained fungal growth
(Figure 5A), high levels of IAld in the stomach (Figure 5B) and
urine (ranges: 0.4–0.5 mg/ml in naive GF mice, 1.1–1.5 mg/ml
in infected GF mice, 5.8–8.7 mg/ml in GF mice + L. reuteri
100-23, 1.2–1.7 mg/ml in GF mice + DLreu4905 mutant, and
0.9–1.4 mg/ml in GF mice + L. johnsonii), IL-22 production (Fig-
ure 5C), increased numbers of IL-22+NKp46+ cells (Figure S7B),
and a visible reduction of the enlarged cecum (Figure S7C).
L. reuteri 100-23, but much less its mutant, similarly provided
antifungal resistance (Figure 5D) and mucosal protection (Fig-
ure S7D) in antibiotic-treated mice, an effect that was depen-
dent on IL-22 and AhR. As in the in vitro setting, the efficacy
of lactobacilli in vivo was independent of IL-17A and adaptive
immunity (Figure S7E). These findings indicate that lactobacilli
promote anticandidal resistance in vivo via host innate mecha-
nisms converging on the AhR-IL-22 axis, although alternative
and/or additional mechanisms of protection are also plausible
(Table S5).
Figure 4. Dietary Trp Affects Levels of IAld and IL-22 in the Stomach
(A–E) Mice were fed a standard (‘‘none’’), low (Trp), or enriched (Trp+) Trp diet for 4 weeks, treated or not with ampicillin (‘‘Amp’’), infected with C. albicans, and
assessed for fungal growth (A), relative Lreu_4905 expression normalized with 16S rRNA (B), peak levels of IAld (C), IL-22 production (D), and percentage of ILC3s
in the stomach (3 dpi) (E). Data represent means ± SD.
(F) Scanning electron microscopy of the stomach after Amp treatment (3 dpi). Scale bars represent 10 mm. Arrows indicate C. albicans cells. Data are repre-
sentative (SEM) of or compiled from four experiments.
(G) Identification of lactobacilli and L. reuteri (red) in the gastric fluids of treated mice by FISH analysis. Bacteria counterstained with DAPI are in blue. Scale bars
represent 10 mm. *p < 0.05, **p < 0.01, ***p < 0.001. Data are representative of two experiments.
Related data are in Figure S6.
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in Candidiasis
‘‘Normal’’ vaginal flora typically shows a predominance of
several Lactobacillus species, which are believed to promote a
healthy vaginal milieu by providing numerical dominance and
by other mechanisms (Lamont et al., 2011). We assessed
whether and which Lactobacillus species would act through
the Ahr-IL-22 axis involving IAld in murine vaginal candidiasis.
Lactobacilli and in particular L. acidophilus, a constituent of the
human vaginal microbiota, were present in the vagina (Figure 6A)
(about 105 to 103 cfu/g of vagina, Ido1/ versus WT mice, by
quantitative cultures in selected media), as detected by FISH
(Figure 6A) and 16S rRNA PCR (Figure 6B). L. acidophilus, recov-ered from the vagina of Ido1/ mice, induced IL-22 (Figure 6C)
and produced IAld in vitro (Figure 6D) and in vivo upon adminis-
tration to GF mice (Figure 6E). IAld was also detected in the
vaginal fluids of conventional mice after the infection (Figure 6F)
(ranges: 12.3–15.7 ng/ml in naive WT mice, 17.6–22.5 ng/ml
in naive Ido1/ mice, 38.4–45.7 ng/ml in infected WT mice,
and 59.6–71.4 ng/ml in infected Ido1/ mice), resistance to
which involved expression of antimicrobial-peptide-encoding
genes (Figure 6G), occurred via IL-22 and AhR (Figure 6H),
and was negated in Ahr/ mice or by IL-22 blockade (Fig-
ure 6I). Therefore, L. acidophilus exploits the IL-22-AhR axis to
provide local resistance to Candida in the vagina, but not in
the stomach, thus explaining why healthy women remainImmunity 39, 372–385, August 22, 2013 ª2013 Elsevier Inc. 379
Figure 5. Probiotic Lactobacilli Exert Species-Specific Effects in Candidiasis
(A–C) Fungal growth (A), IAld (B), and IL-22 (C) levels in the stomachs (3 dpi) of GFmice untreated (‘‘none’’) or monoassociated by gavagewith L. reuteri 100-23, its
DLreu4905 mutant, and L. johnsonii before the C. albicans intragastric infection.
(D) Fungal growth in the stomach of conventional mice untreated (‘‘none’’) or monoassociated with L. reuteri 100-23 or its DLreu4905 mutant and infected with
C. albicans. Mice were treated with vancomycin, neomycin, ampicillin, and metronidazole (‘‘V/A/N/M’’) for 4 weeks. ‘‘Ct’’ indicates the control mice, which were
infected only. Fecal counts of lactobacilli and Gram staining revealed colonization at necroscopy. Data are compiled from three experiments and represent the
mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001. ‘‘NS’’ stands for not significant.
Related data are in Figure S7.
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(Sobel, 2007).
IAld Administration Provides Antifungal Resistance and
Mucosal Protection
The ability of IAld to act as an AhR ligand and to promote IL-22
production led us to assess whether IAld could be exploited to
provide antifungal resistance and mucosal protection from
inflammation. We administered IAld to WT and Ahr/ mice
with mucosal candidiasis or with dextran sodium sulfate
(DSS)-induced colitis, a model in which AhR signaling inhibits
inflammation via IL-22 (Monteleone et al., 2011). IAld restored
antifungal resistance (Figure 7A) and IL-22 production (Figure 7B)
upon infection, ameliorated colitis (Figures 7C and 7D), and
induced IL-22 production by colonic NKp46+ cells (Figure 7E)
in WT mice. These effects were not seen in Ahr/mice (Figures
7A–7E). Considering that defective Th1 and Treg cell adaptive
immune responses—required for clearing the fungus and pre-
venting infection-associated chronic inflammation (De Luca
et al., 2010)—are observed in Ido1/ mice (Figure S8), these
data clearly indicate that the AhR agonistic activity of IAld could
be exploited to provide homeostasis and microbial symbiosis at
mucosal surfaces in conditions of impaired adaptive immunity.
DISCUSSION
Our study discloses a signaling pathway that links the bacterial-
fungal population dynamicswith themammalian host atmucosal
surfaces. A microbial Trp metabolic pathway appeared to be
evolved to preserve immune physiology at mucosal surfaces
via recruitment of host cells competent for AhR-regulated Il22380 Immunity 39, 372–385, August 22, 2013 ª2013 Elsevier Inc.transcription. The IL-22-regulated mucosal response allows for
survival of mixed microbial communities yet provides coloniza-
tion resistance toC. albicans. Infections caused by opportunistic
fungi have traditionally been viewed as the gross result of a path-
ogenic automatism, which makes a weakened host more vulner-
able to microbial insults. Our study reveals that fungal interaction
with the host is more complex than previously appreciated
because it includes a triad interaction with indigenous bacteria.
It is known that lactobacilli promote specific immune and
metabolic processes in a strain-specific manner (Tannock,
2004; van Baarlen et al., 2011) and that ‘‘metabolic products of
the lactobacillus population in the stomach could influence the
physiology of the adjacent tissues of the host’’ (Tannock,
2004). The stomach favors the colonization of acid-resistant lac-
tobacilli and is a normal habitat of various fungal taxa in rodents
and humans, where yeasts are associated with the mucin layer
covering the secreting epithelial cells (Karczewska et al., 2009;
Scupham et al., 2006; Tannock and Savage, 1974). Within the
stomach, lactobacilli are known to promote resistance to coloni-
zation by the fungus (Noverr and Huffnagle, 2004; Savage, 1969)
and to be antagonized by C. albicans during postantibiotic
recolonization and gastritis (Mason et al., 2012). Decreased lac-
tobacilli content is indeed associated with sustained gastric
colonization by the fungus in wasting nude mice (Brown and Bal-
ish, 1978) or mice fed a purified diet (Yamaguchi et al., 2005).
Thus, a functional interplay between C. albicans and lactobacilli
does occur, a disturbance of which might affect microbial sym-
biosis and C. albicans mutualism. Although the mechanisms of
protection might include the production of other mediators (Vol-
tan et al., 2008) and direct microbial antagonism by lactobacilli
(Noverr and Huffnagle, 2004) and IAld (Table S5), both affecting
Figure 6. L. acidophilus Provides Protection in Vaginal Candidiasis through the AhR-IL-22 Axis
(A and B) Detection of lactobacilli and L. acidophilus by FISH analysis (red bacteria) (A) and 16S rRNA RT-PCR (B) in the vagina of mice intravaginally infected with
C. albicans blastospores (3 dpi). ‘‘Ct’’ stands for pure cultures of bacteria. Bacteria counterstained with DAPI are in blue. Scale bars represent 10 mm.
(C) IL-22 levels in ex vivo vaginal tissue exposed to inactivated L. acidophilus or L. acidophilus grown in PT-CM or MRS-CM. ‘‘None’’ indicates PT alone.
**p < 0.01, ***p < 0.001.
(D–F) Peak levels of IAld in supernatants of L. acidophilus grown in PT-CM versus MRS-CM (D), vaginal fluids of GF mice, naive or infected and/or mono-
associatedwith L. acidophilus (E), and naive or infected conventionalmice at 3 dpi (F). Abbreviations are as follows: IAM, indole-3-acetamide; IAA, indole-3-acetic
acid; and ILA, indole-3-lactic acid.
(G–I) Expression of antimicrobial-peptide-encoding genes (G), IL-22 levels (H), and fungal growth (I) in the vagina of mice treated with mAb neutralizing IL-22 or
isotype control antibody (‘‘none’’).
Data are representative (FISH and RT-PCR) of or compiled from three experiments and represented as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001.
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action between commensal fungi and the host’s immune system
via local microbiota determines their position from commensals
to pathogens and why this position can change continuously
(Romani, 2011).
Through the activation of local metabolic pathways involving
AhR and converging on IL-22, lactobacilli mediated mucosal
antifungal resistance that was contingent upon the host meta-
bolic environment, involved microbial adaptation, and was
modulated by diet. In mice, autochthonous SFB are responsible
for Th17 accumulation and IL-22 production by Th17 cells in the
gut (Ivanov et al., 2009), but it has been unclear whether andwhich signals from the microbiota selectively direct the produc-
tion of IL-22 by ILC3s (Lee et al., 2012). A substantial reduction
in IL-22+NKp46+ pool size was observed in the gut upon deple-
tion of lactobacilli, whereas monoassociation with L. reuteri
increased IL-22 production by NKp46+ cells in GF mice, thus
revealing that certain Lactobacillus species stimulate ILC3s for
IL-22 production, an effect carried out in a strain-specific
manner, as typically occurs (Tannock, 2004; van Baarlen
et al., 2011).
Although lactobacilli share with Gram-positive bacteria the
ability to stimulate IL-22 production via TLR2, the metabolic
pathway of IL-22 production via AhR stimulation by IAldImmunity 39, 372–385, August 22, 2013 ª2013 Elsevier Inc. 381
Figure 7. IAld Protects against Candidiasis and Colitis
(A and B) Fungal growth (A) and IL-22 production (B) in untreated (‘‘none’’) or
IAld-treated C. albicans-infected mice. Error bars represent the SD of samples
within a group. *p < 0.05, ***p < 0.001. ‘‘NS’’ stands for not significant.
(C–E) Percentage body weight (C), colon histopathology (hematoxylin and
eosin; scale bars represent 200 mm) (D), and detection of colonic NKp46+IL-
22+ cells by immunofluorescence (E) in DSS-treatedmice that received vehicle
alone (‘‘none’’) or IAld intragastrically (day 12 after DSS challenge). Scale bars
represent 20 mm. Data are representative (histology and immunofluorescence)
of or compiled from three experiments and represented as mean ± SD. Error
bars represent the SD of samples within a group.
(F) Proposed model for the role of IDO1 in the host-microbiota symbiotic
relationship. Besides the immunomodulatory activity of the host’s own
Immunity
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382 Immunity 39, 372–385, August 22, 2013 ª2013 Elsevier Inc.occurred as a result of their microbial adaptation. Lactobacilli are
phylogenetically closely related by their small genomes and
common metabolic pathways for sugar fermentation and lactic
acid production, and they occupy a diverse set of ecological
niches as a result of considerable genetic adaptation (Frese
et al., 2011). Both L. johnsonii (Denou et al., 2007) and
L. reuteri (Walter et al., 2011) are transcriptionally very active in
the mouse forestomach, where carbohydrate partitioning pro-
vides niche differentiation that allows cohabitation by the two
strains (Tannock et al., 2012). We found in this study that, in addi-
tion to sugar, amino acid partitioning might also crucially affect
cohabitation of the strains in the stomach, where amino
acid digestion is crucial for L. reuteri expansion. Accordingly,
L. reuteri not only expanded but also expressed Lreu23-
DRAFT_4905, encoding ArAT, in the presence of Trp. Thus,
L. reuteri, more than L. johnsonii, is competent for Trp utilization
in the stomach. Similar to L. reuteri, L. acidophilus is competent
for Trp utilization in the vagina, and together these findings
highlight the organ-specific dependency of the host-microbiota
interaction at the mucosal surfaces.
The species-specific effects of lactobacilli on C. albicans
colonization might offer a plausible explanation for the organ
tropism of mucosal candidiasis in mice and humans, for the
susceptibility to infection in specific clinical settings, and for
the variable and inconsistent effects of probiotic administration
in human candidiasis. Because lactobacilli are greatly reduced
in the neonatal period (Sjo¨gren et al., 2009) and by stress (Lut-
gendorff et al., 2008; Tannock and Savage, 1974), our data are
consistent with the occurrence of neonatal and vaginal candi-
diasis, clinical conditions under which the empirical use of
lactobacilli as probiotics to prevent infection has long been
advocated (Falagas et al., 2006; Manzoni et al., 2006) but never
mechanistically explained. Moreover, the very high diversity of
Lactobacillus spp. in the human vagina (Human Microbiome
Project Consortium, 2012) might offer a plausible explanation
for the idiopathic recurrence of vaginal candidiasis in the relative
absence of recognized risk factors (Sobel, 2007). We also antic-
ipate that responsiveness to the different lactobacilli probiotic
species is determined not only by the characteristics of the
consumed strains but also by microbial adaptation, metabolic,
and nutritional status of the host. On a translational level,
considering that probiotic L. reuteri of human origin also pro-
duced IAld upon growing on Trp (data not shown), these find-
ings imply that Trp supplementation in the context of antibiotic
coverage might optimize antifungal and probiotic therapy and,
most likely, immune physiology (Li et al., 2011). We also found
that IAld could substitute for probiotics in protecting and main-
taining mucosal integrity during infectious or chemical damage,
a finding pointing to the possible use of IAld as a supportive
therapy during flora manipulation and intestinal dysbiosis.
In this regard, loss of overall diversity and expansion of lacto-
bacilli has been described in murine and human recipients ofkynurenine production, by regulating the local amino acid levels and
consequently the size and metabolic activity of gut microbiota, IDO1 might
be a key molecule in directing the host-microbiota symbiotic relationship
and its integration within the innate and adaptive immune systems of verte-
brate hosts.
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the predominant species of Lactobacillus induced significant
protection against graft-versus-host disease (Jenq et al.,
2012). Considering the reciprocal influence between the fungal
community in the gut and local levels of inflammation (Iliev
et al., 2012), IAld might represent a prototypical candidate
capable of multitasking effectively in transplanted recipients
and patients with mucosal inflammatory diseases. The flipside
will be the generation of potentially harmful proinflammatory
effects of IL-22, such as psoriasis in susceptible hosts.
In conclusion, although the enzyme Trp 2,3-dioxygenase
(Opitz et al., 2011), mainly expressed in the liver, regulates Trp
concentrations after nutritional Trp uptake under normal circum-
stances, the high amounts of IDO1 expression at mucosal sites
during immune activation (Dai and Zhu, 2010) point to IDO1 as
the dominant enzyme regulating the local amino acid nutrient
levels, the size and metabolic activity of gut microbiota, and,
owing to the host’s own immunomodulatory activity via L-kynur-
enine production, mucosal immune reactivity. Thus, these data
qualify IDO1 as a key molecule in dictating host-microbiota
symbiotic relationships and their integration within the adaptive
immunity of vertebrate hosts (Figure 7F).EXPERIMENTAL PROCEDURES
A detailed description of the experimental procedures used in this paper can
be found in the Supplemental Information.Mice, Infections, Colitis, and Treatments
C57BL/6mice, 8–10 weeks old, were purchased from The Jackson Laboratory
and Charles River Laboratories. Breeder pairs of Ido1/mice were purchased
from The Jackson Laboratory. Homozygous SCID mice on a BALB/c
background and Tlr2/,Myd88/,Ahr/, Il17a/mice on a C57BL/6 back-
ground were bred under specific pathogen-free conditions at the Animal
Facility of Perugia University. Mice were housed in specific pathogen-free
barrier facilities at the Animal Facility of Perugia University. Female 8-week-
old GF C3H/Orl mice were purchased from The Jackson Laboratory and
housed in isolators and fed an irradiated standard rodent chow diet (Muce-
dola). For infections and colitis, see Supplemental Information. GF mice
were monoassociated with a single gavage (gastrointestinal candidiasis) or
intravaginal injection (vaginal candidiasis) of 109 cfu of lactobacilli 1 day before
infection. For Trp supplementation, mice were fed the control diet supple-
mented with 1g/kg Trp. The composition of the diets and their final Trp levels
are listed in Table S6. For metagenomic analysis, littermates from Ido1+/ 3
Ido1+/ crosses, kept in the same cage, were compared. Control littermates
were included in individual experiments so that nonspecific effects of each
genetic manipulation could be checked for, but none were found. See also
Supplemental Information.Microbiota Analysis by 16S rRNA Sequencing
Bacterial DNA from gastric fluids and feces of eight mice from each group was
extracted with the QIAamp DNAMini Kit (QIAgen). For each sample, 16S rRNA
genes were amplified with a composite forward primer and a reverse primer
containing a unique 12-base barcode used for tagging each PCR product.
For each sample, five replicate PCR products were combined and purified
with Ampure XP magnetic purification beads (Agencourt Bioscience), and
products were quantified with the Quant-iT PicoGreen dsDNA Assay Kit
(Invitrogen). All libraries were subjected to quality control with the DNA 1000
Agilent Bioanalyzer (Agilent Technologies). Two master DNA libraries were
generated from the purified products in equimolar ratios to final concentrations
of 35.6 and 33.9 ng/ml. The pooled products were sequenced with a Roche
454 GS Titanium pyrosequencer at the BMR Genomics genome sequencer
center at the University of Padova.Data Analysis and Sequence Classification
A total of 620,369 reads with a median length of 365.4 bp were obtained for
all samples in both libraries. For making phylogenetic assignments, reads
were clustered against a high-quality seed library with the use of CD-HIT
454 with a 97% similarity cutoff. Species names were assigned to OTUs
with Ribosomal Database Project SeqMatch (http://rdp.cme.msu.edu/
seqmatch/seqmatch.jsp). Weighted and unweighted UniFrac distances
were calculated and principal-coordinate analyses were performed with
QIIME software.
Quantification of Gut Microbiota by Culture Method and by
Qualitative and Quantitative PCR
See Supplemental Information.
Bacterial Strains and Cultures
Lactobacilli were isolated from the stomach of Ido1/ infected mice, as pre-
viously described (Roach et al., 1977). The isolates were identified as lacto-
bacilli on the basis of Gram-stain morphology and by the API 50 CHG system
(BioMe´rieux Italia). For obtaining lactobacilli from the murine stomach,
gastric fluids were plated on Man-Rogosa-Sharpe (MRS) agar plates and
were incubated anaerobically at 37C for at least 3 days, after which visible
colonies were selected and cultured anaerobically in MRS broth at 37C.
DNA was extracted from isolated colonies as described in the Supplemental
Information. The obtained sequences were subjected to BLAST analysis
(http://www.ncbi.nlm.nih.gov/BLAST/) for the identification of Lactobacillus
species. Murine L. intestinalis, murinus, gasseri, animalis, helveticus, and
crispatus were purchased from Leibniz Institut DSMZ-German Collection of
Microorganisms and Cell Cultures (Brunswick). E. coli, Clostridia, Entero-
cocci, and Bacteroidetes were obtained from mice specimens derived
from the gastrointestinal tract and were isolated with the use of selective
media.
Generation of the L. reuteri DLreu4905 Mutant
The aromatic amino acid aminotransferase nucleotide sequences of L. reuteri
DSM 20016 (NCBI GI 148530277, Lreu_0044) and JCM 1112 (NCBI GI
183223999, LAR_0041) were used for identifying a homologous gene in the
genome of L. reuteri 100-23 (http://www.jgi.dow.gov/). The locus of the gene
encoding the putative aromatic amino acid aminotransferase and flanking
nucleotide sequences in L. reuteri 100-23 were analyzed with the BLASTx
program against the NCBI databases (http://blast.ncbi.nlm.nih.gov/Blast.
cgi). The gene coding for aminotransferase class I and II (Lreu23DRAFT_4905,
referred to as Lreu4905) in L. reuteri 100-23 was truncated with the use of
pJRS233 according to a deletion strategy described earlier (see Supplemental
Information for references). Transformants were grown in mMRS-erythro-
mycin broth at 42–44C for 80 generations for the selection of single-crossover
mutants.
Immunohistochemistry and FISH
Organs were removed and fixed in 10% phosphate-buffered formalin,
embedded in paraffin, and sectioned at 5 mm. Sections were then rehydrated,
and after antigen retrieval in Citrate Buffer (10 mM, pH6), sections were
blocked with 5% BSA in PBS and stained with PE anti-iL-22 and FITC-anti-
NKp46 (eBioscience). mAbs were incubated overnight at 4C. Images were
acquired with a fluorescence microscope (BX51 Olympus) with a 403 objec-
tive and the analySIS image processing software (Olympus). DAPI (Molecular
Probes) was used for counterstaining tissues and detecting nuclei. FISH anal-
ysis with fluorescently labeled specific probes was done in gastric and vaginal
fluids (see Supplemental Information). Images were acquired with a fluo-
rescence microscope (BX51 Olympus) and the analySIS image processing
software (Olympus).
HPLC-HRMS Analysis
For metabolomic analysis, HPLC-HRMS (high-performance liquid chromatog-
raphy-high-resolution mass spectrometry) was performed with both the 1290
Infinity HPLC coupled to a 6540Q-ToFmass spectrometer equippedwith a Jet
Stream ESI interface (Agilent Technologies) and the Ultimate 3000 HPLC
coupled to a LTQ-Orbitrap mass spectrometer through an ESI interface
(Thermo Scientific) (see Supplemental Information).Immunity 39, 372–385, August 22, 2013 ª2013 Elsevier Inc. 383
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Data are expressed as mean ± SD. Horizontal bars indicate the means. For
multiple comparisons, p values were calculated by a one-way ANOVA (Bonfer-
roni’s post hoc test). For single comparison, p valueswere calculated by a two-
tailed Student’s t test. The data reported are either from one representative
experiment out of three to five independent experiments or compiled from
three to five experiments.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
eight figures, and eight tables and can be found with this article online at
http://dx.doi.org/10.1016/j.immuni.2013.08.003.
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